Clinical Trials on Ovarian Cancer.
Total 53605 results
-
Grupo Español de Investigación en Cáncer de OvarioRoche Pharma AGTerminated
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Brenner Tumor | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous Cystadenocarcinoma | Ovarian Undifferentiated AdenocarcinomaUnited States
-
Southern Illinois UniversityCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Eli Lilly and CompanyCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Australia, Germany, Belgium
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); BayerTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity CancerUnited States
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Incyte CorporationActive, not recruitingRecurrent Fallopian Tube Cancer | Recurrent Epithelial Ovarian Cancer | Recurrent Peritoneal CancerUnited States, Canada
-
Centre Francois BaclesseGroupement Interrégional de Recherche Clinique et d'InnovationCompletedOvarian Cancer With Peritoneal CarcinosisFrance
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer CenterCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Dana-Farber Cancer InstituteNovartisTerminatedMetastatic Hormone-Receptor-Positive (HR+) Breast Cancer | HER2-Negative Breast Cancer | Metastatic Epithelial Ovarian CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingPeritoneal Carcinoma | Stage III Fallopian Tube Cancer | Stage II Fallopian Tube Cancer | Ovarian Epithelial Cancer Stage I | Ovarian Epithelial Cancer Stage II | Ovarian Epithelial Cancer Stage III | Stage I Fallopian Tube CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Fallopian Tube Cancer Stage IV | Fallopian Tube Cancer Stage IIIUnited States
-
Ling-Ying WuNot yet recruiting
-
AGO Research GmbHRecruitingEpithelial Ovarian CancerGermany
-
Groupe Hospitalier Diaconesses Croix Saint-SimonGERCOR - Multidisciplinary Oncology Cooperative GroupRecruitingOvarian Cancer, EpithelialFrance
-
Grupo Español de Investigación en Cáncer de OvarioAstraZenecaCompletedAdvanced Ovarian CancerSpain
-
Opna-IO LLCTerminatedEpithelial Ovarian Cancer | Gynecologic NeoplasmsUnited States, Canada
-
Shanghai East HospitalAnhui Provincial Hospital; Nanjing Legend Biotech Co.; East Clinical Center of...Terminated
-
Translational Research in OncologyCelgeneTerminatedEpithelial Ovarian CancerUnited States
-
Jun ZhangCompletedAdvanced Ovarian CancerChina
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedMetastatic Ovarian CancerFrance
-
RenJi HospitalCompletedEpithelial Ovarian CancerChina
-
Merck Sharp & Dohme LLCCompleted
-
Asan Medical CenterSanofiCompletedAdvanced Ovarian CancerKorea, Republic of
-
Prima BioMed LtdCompleted
-
Grupo Español de Investigación en Cáncer de OvarioCompletedPlatinum-resistant Advanced Ovarian CancerSpain
-
ARCAGY/ GINECO GROUPRoche Pharma AGCompleted
-
Translational Research in OncologyTerminatedOvarian NeoplasmsUnited States, France, Germany, Israel, Ireland, Spain, Canada, United Kingdom
-
MorphotekCompletedEpithelial Ovarian CancerUnited States
-
Russian Academy of Medical SciencesUnknownOvarian CancerRussian Federation
-
Cancer Research UKCompletedOvarian CancerUnited Kingdom
-
Sun Yat-sen UniversityHutchmedRecruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma | Fallopian Tube CarcinosarcomaChina
-
Shanghai Gynecologic Oncology GroupZhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; Shanghai Zhongshan...Active, not recruitingFallopian Tube Carcinoma | Ovarian Epithelial Cancer Recurrent | Primary Peritoneal CarcinomaChina
-
Gdynia Oncology CenterSuspendedMalnutrition | Ovarian Epithelial Cancer | AscitesPoland
-
Catholic University of the Sacred HeartCompletedOvarian Epithelial Cancer Recurrent
-
AGO Study GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical...CompletedOvarian CancerCanada, United States
-
Daiichi Sankyo, Inc.CompletedAdvanced Solid Malignant Tumors | Advanced Ovarian CancerUnited States
-
AbbVieCompletedOncology | High Grade Serous Ovarian Cancer | BRCA Mutated | BRCA Mutated Breast Cancer
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.RecruitingAdvanced Ovarian CancerChina
-
Japanese Gynecologic Oncology GroupKorean Gynecologic Oncology GroupRecruitingEpithelial Ovarian CancerJapan, Korea, Republic of
-
Women's Hospital School Of Medicine Zhejiang UniversityActive, not recruiting
-
Baylor Research InstituteActive, not recruitingEpithelial Ovarian CancerUnited States
-
MorphotekTerminatedEpithelial Ovarian CancerUnited States, Germany
-
PharmaMarCompletedRelapsed Ovarian CancerSpain, France, Italy, Belgium, Germany
-
Universitaire Ziekenhuizen KU LeuvenAstraZenecaActive, not recruitingOvarian Epithelial CancerBelgium
-
Chang Gung Memorial HospitalHoffmann-La Roche; Asian Gynecologic Oncology Group; Taiwanese Gynecolgic Oncology...CompletedEpithelial Ovarian CancerTaiwan
-
Immetacyte LtdWithdrawnOvarian Cancer MetastaticUnited Kingdom
-
Qianfoshan HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.UnknownImmune Checkpoint InhibitionChina